ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 1702.3 | 1565.2 | 1900.5 |
| Other income | 64.1 | 75.6 | 85.9 |
| Total income | 1766.4 | 1640.8 | 1986.4 |
| Profit before exceptional items & tax | 321.8 | 302.5 | 507.4 |
| Exceptional items | 0.0 | -2.0 | 0.0 |
| Profit before tax | 321.8 | 300.5 | 507.4 |
| Net profit | 244.2 | 200.2 | 400.0 |
| Operating margin | 18.2% | 18.3% | 25.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -39.00% |
|---|---|
| Net profit, quarter on quarter | +22.00% |
| Revenue, year on year | -10.40% |
| Operating profit, year on year | -38.90% |
| Operating profit, quarter on quarter | +13.60% |
BSE results filing, NSE: PIIND. Figures extracted from the filing.
PI Industries Ltd: key numbers
- Share price
- ₹1,761.00
- Market cap
- ₹26,718 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 30.4×Sector 35.5×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Earnings Call Transcript: Key Takeaways
PI Industries faces severe headwinds in its core AgChem export business, masking strong domestic and biological growth.
PI Industries Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue fell 9% to INR17,018Mn, EBITDA margin compressed to 14%, and PAT fell 70%. Domestic and Biologicals grew; agchem exports declined 18%.
PI Industries Q2 FY27 Results: Net Profit ₹122.2 Cr, Down 70.1% YoY
PI Industries Ltd reported revenue from operations of ₹1,702 Cr (-9.1% YoY) and net profit of ₹122.2 Cr (-70.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹122.2 Cr · -70.1% YoY
PI Industries Business Update
PI Industries unveiled Pioxaniliprole, India's first indigenously discovered insecticide molecule, which has received CIB&RC registration. The press release marks a milestone in the company's original crop-protection research.
PI Industries Board Meeting Date
PI Industries has intimated a board meeting on November 4, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window is closed from October 1 to November 6, 2026.
PI Industries Other Announcement
PI Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations. This is a routine regulatory compliance filing.